Börse:
4,370€
-1,52%
Echtzeit-Aktienkurs AB Science, Paris
Bid:
4,340€
Ask:
4,400€
| Allgemeine Informationen | ||
|---|---|---|
| Börsenwert: | 179,30 Mio. EUR (41,03 Mio. x 4,370€) | |
| Website: | - | |
| Sektor: | - | |
| News-Radar | |
|---|---|
| dpa-AFX Pro - | Newsbot - |
| dpa-AFX - | Reuters - |
| 2016 | 2017 | 2018 | |
|---|---|---|---|
| KUV | 111,78 | 103,01 | 105,41 |
| KGV | - | - | - |
| Div. Rend. | - | - | - |
Echtzeit-Chart der AB Science, Paris Aktie
Börsenkurse AB Science, Paris
| Tradegate | 4,340€ | 231 | 4,400€ | 228 | 4,370€ | -1,52% |
| Euro Indikation | 4,340€ | 0 | 4,400€ | 0 | 4,370€ | -1,80% |
| Lang & Schwarz | 4,360€ | 1143 | 4,390€ | 1143 | 4,375€ | -1,42% |
| Börse Stuttgart | 4,340€ | 0 | 4,400€ | 0 | 4,370€ | -0,34% |
Fundamentaldaten der AB Science, Paris Aktie
Aktuelle Geschäftsentwicklung
Sie benötigen die TraderFox Börsensoftware, um die aktuelle Geschäftsentwicklung einsehen zu können.
Income Statement: 10-Year-Summary
| Datum | Umsatz | EBIT | Gewinn | EPS | Dividende | KGV | KUV |
|---|---|---|---|---|---|---|---|
| 2018 | 1,70 Mio. | -31,74 Mio. | -26,06 Mio. | -0,69 | 0,00% | - | 105,41 |
| 2017 | 1,74 Mio. | -33,67 Mio. | -27,12 Mio. | -0,75 | 0,00% | - | 103,01 |
| 2016 | 1,51 Mio. | -34,60 Mio. | -27,70 Mio. | -0,78 | 0,00% | - | 111,78 |
Profil der AB Science, Paris Aktie
AB Science SA engages in the pharmaceutical industry. The firm develops tyrosine kinase inhibitor drugs which are used against cancer, inflammatory, and central nervous system diseases. It also engages in the field of veterinary medicine. The company was founded by Alain Moussy on July 11, 2001 and is headquartered in Paris, France.
TraderFox GmbH:
Impressum & Datenschutz -
Allgemeine Geschäftsbedingungen